심뇌혈관 및 대사질환 원인연구센터

연구논문Paper

비회원이 작성한 글입니다!

로그인 또는 글작성시 입력했던 비밀번호를 입력해주세요.

목록 윗글 아랫글
게시글 내용
[1세부]Research: Epidemiology Performance of HbA1c for the prediction of diabetes in a rural community in Korea
2015/05/22
DIABETICMedicine DOI: 10.1111/dme.12794
 

Research: Epidemiology
Performance of HbA1c for the prediction of diabetes in a rural community in Korea




B. M. Song1,2, H. C. Kim2,3, J. Y. Lee3, J.-M. Lee2,3, D. J. Kim2,5, Y.-H. Lee4 and I. Suh3
 

Abstract



Aim To investigate the performance of HbA1c in predicting incident diabetes among Korean adults with normal fasting glucose and impaired fasting glucose levels.

Methods This study used data from the Korean Genome Epidemiology Study-Kangwha Study. A prospective analysis was carried out on 2079 people (820 men and 1259 women) who completed follow-up examinations up until 2013. Diabetes was defined as fasting blood glucose level  7.0 mmol/l, HbA1c level  48 mmol/mol (6.5%), or current treatment for diabetes. Areas under the receiver-operating characteristic curves were used to assess the different performances of HbA1c, glucose and insulin in predicting diabetes.

Results The median follow-up time was 3.97 years, during which 7.7% of men and 6.3% of women developed incident diabetes. The areas under the receiver-operating curves (95% CI) for diabetes prediction were 0.740 (0.692–0.787) for HbA1c, 0.716 (0.667–0.764) for glucose and 0.598 (0.549–0.648) for insulin. HbA1c showed better predictive power in people with impaired fasting glucose (area under the curve 0.753, 95% CI 0.685–0.821) than in those with normal glucose (area under the curve 0.648, 95% CI 0.577–0.719). An HbA1c threshold of 40 mmol/mol (5.8%) was found to have the highest predictive value for diabetes, with a relative risk of 6.30 (95% CI 3.49–11.35) in men and 3.52 (95% CI 2.06–6.03) in women after adjusting for age, waist circumference, triglycerides, hypertension, family history of diabetes, smoking, alcohol intake, exercise and baseline glucose level.

Conclusions HbA1c can be used to identify people at high risk for the development of diabetes, especially in those with impaired fasting glucose levels.

Diabet. Med. 00, 000–000 (2015)
목록 윗글 아랫글